COHERENT OPAL PHOTOACTIVATOR LASER SYSTEM

System, Laser, Photodynamic Therapy

FDA Premarket Approval P990049

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the treatment of age-related macular degeneration in patients with predominantly classic subfoveal choroidal neovascularization.

DeviceCOHERENT OPAL PHOTOACTIVATOR LASER SYSTEM
Classification NameSystem, Laser, Photodynamic Therapy
Generic NameSystem, Laser, Photodynamic Therapy
ApplicantLUMENIS
Date Received1999-08-20
Decision Date2000-04-12
Notice Date2000-04-12
PMAP990049
SupplementS
Product CodeMVF
Docket Number00M-1299
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product Yes
Applicant Address LUMENIS 3959 West 1820 South salt Lake City, UT 84104
Summary:Summary of Safety and Effectiveness
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990049Original Filing
S001 2000-08-16 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.